Cytokinetics CYTK Derivative Gain Loss On Derivative Net
Derivative Gain Loss On Derivative Net at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:DerivativeGainLossOnDerivativeNet.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's derivative gain loss on derivative net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's derivative gain loss on derivative net?
- Cytokinetics (CYTK) reported derivative gain loss on derivative net of $1.5M in Q1 2026.
- How has Cytokinetics's derivative gain loss on derivative net changed year-over-year?
- Cytokinetics's derivative gain loss on derivative net increased by 475.0% year-over-year, from -$400K to $1.5M.
- What does derivative gain loss on derivative net mean?
- The non-cash gain or loss from changes in the value of financial derivatives.
- How do you interpret derivative gain loss on derivative net?
- Gains indicate favorable market movements for the company's derivative positions.
- How does derivative gain loss on derivative net compare across companies?
- Common for companies with significant currency or interest rate hedging programs.